Picture of Kalvista Pharmaceuticals logo

KALV — Kalvista Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Brief: Kalvista Pharmaceuticals Q3 Net Income USD -44.262 Million

Mar 12 (Reuters) - Kalvista Pharmaceuticals Q3 basic EPS USD -0.92.

Q3 operating expenses USD 42.94 million

Q3 operating income USD -42.94 million

Recent news on Kalvista Pharmaceuticals

See all news